Heron Therapeutics (NASDAQ:HRTX) PT Lowered to $4.00 at Needham & Company LLC
Heron Therapeutics (NASDAQ:HRTX – Free Report) had its target price reduced by Needham & Company LLC from $5.00 to $4.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Separately, StockNews.com lowered Heron Therapeutics from a hold rating to a sell rating […]
More Stories
Semus Wealth Partners LLC Acquires 5,458 Shares of JPMorgan Hedged Equity Laddered Overlay ETF (NYSEARCA:HELO)
Semus Wealth Partners LLC raised its holdings in JPMorgan Hedged Equity Laddered Overlay ETF (NYSEARCA:HELO – Free Report) by 136.4%...
Semus Wealth Partners LLC Makes New $417,000 Investment in FT Vest U.S. Equity Buffer ETF – September (BATS:FSEP)
Semus Wealth Partners LLC acquired a new position in shares of FT Vest U.S. Equity Buffer ETF – September (BATS:FSEP...
CAP Partners LLC Trims Position in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI)
CAP Partners LLC lowered its position in JPMorgan Equity Premium Income ETF (NYSEARCA:JEPI – Free Report) by 17.0% in the...
Capital City Trust Co. FL Acquires New Position in Vanguard Growth ETF (NYSEARCA:VUG)
Capital City Trust Co. FL bought a new position in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) during...
Strengthening Families & Communities LLC Buys 3,610 Shares of Newmont Co. (NYSE:NEM)
Strengthening Families & Communities LLC increased its holdings in Newmont Co. (NYSE:NEM – Free Report) by 8.8% during the 3rd...
Ulta Beauty, Inc. (NASDAQ:ULTA) Shares Acquired by Mawer Investment Management Ltd.
Mawer Investment Management Ltd. increased its stake in Ulta Beauty, Inc. (NASDAQ:ULTA – Free Report) by 3.2% during the 3rd...